Baylor College of Medicine: Proteomics Analysis IDs Potential Drug Targets for Aggressive Cancers
March 05, 2021
March 05, 2021
HOUSTON, Texas, March 5 (TNSJou) -- The Baylor College of Medicine issued the following news release:
Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful approach to identify potential novel therapeutic targets. They report in the journal Oncogene, the identification of "proteomic signatures" that are associated with clinical measures of aggressive disease for each of the seven c . . .
Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful approach to identify potential novel therapeutic targets. They report in the journal Oncogene, the identification of "proteomic signatures" that are associated with clinical measures of aggressive disease for each of the seven c . . .